Jennifer Doan

Array ( [id] => 7634677 [patent_doc_number] => 06656942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Orally active salts with tyrosine kinase activity' [patent_app_type] => B2 [patent_app_number] => 09/981979 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17866 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656942.pdf [firstpage_image] =>[orig_patent_app_number] => 09981979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951386 [patent_doc_number] => 06960590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Orally active salts with tyrosine kinase activity' [patent_app_type] => utility [patent_app_number] => 10/398851 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18226 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960590.pdf [firstpage_image] =>[orig_patent_app_number] => 10398851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236061 [patent_doc_number] => 06689792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Antipsychotic indolyl derivatives' [patent_app_type] => B2 [patent_app_number] => 09/976321 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4332 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689792.pdf [firstpage_image] =>[orig_patent_app_number] => 09976321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017018 [patent_doc_number] => 20020103198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Acylamino cyclopropane derivatives' [patent_app_type] => new [patent_app_number] => 09/973615 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10127 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103198.pdf [firstpage_image] =>[orig_patent_app_number] => 09973615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243190 [patent_doc_number] => 20020045628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression' [patent_app_type] => new [patent_app_number] => 09/969910 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18996 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045628.pdf [firstpage_image] =>[orig_patent_app_number] => 09969910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468280 [patent_doc_number] => 20040053929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => '1, 2, 5, 10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain' [patent_app_type] => new [patent_app_number] => 10/381921 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12017 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053929.pdf [firstpage_image] =>[orig_patent_app_number] => 10381921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468286 [patent_doc_number] => 20040053930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => '7-Chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain' [patent_app_type] => new [patent_app_number] => 10/381922 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9545 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053930.pdf [firstpage_image] =>[orig_patent_app_number] => 10381922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117243 [patent_doc_number] => 20050070544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => '1,2,5,10-tetrahydropyridazino{4,5-b}quinoline-1,10-diones and their use for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 10/381914 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8303 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070544.pdf [firstpage_image] =>[orig_patent_app_number] => 10381914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403904 [patent_doc_number] => 06538135 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)' [patent_app_type] => B1 [patent_app_number] => 09/937812 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2513 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538135.pdf [firstpage_image] =>[orig_patent_app_number] => 09937812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599132 [patent_doc_number] => 20020042421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Substituted 1,4-dihydropyridine compounds as bradykinin antagonists' [patent_app_type] => new [patent_app_number] => 09/964907 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28061 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042421.pdf [firstpage_image] =>[orig_patent_app_number] => 09964907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923289 [patent_doc_number] => 20020115663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 09/963733 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22884 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115663.pdf [firstpage_image] =>[orig_patent_app_number] => 09963733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1334982 [patent_doc_number] => 06596866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Process for the preparation of nefazodone hydrochloride' [patent_app_type] => B2 [patent_app_number] => 09/953167 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2338 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596866.pdf [firstpage_image] =>[orig_patent_app_number] => 09953167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276656 [patent_doc_number] => 20040236107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Intermediate compounds for the preparation of mirtazapine and the production methods thereof' [patent_app_type] => new [patent_app_number] => 10/488909 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2963 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236107.pdf [firstpage_image] =>[orig_patent_app_number] => 10488909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083091 [patent_doc_number] => 20020082421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide' [patent_app_type] => new [patent_app_number] => 09/950502 [patent_app_country] => US [patent_app_date] => 2001-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6469 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082421.pdf [firstpage_image] =>[orig_patent_app_number] => 09950502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417865 [patent_doc_number] => 06518273 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => '2-aryl indole derivative as antagonists of tachykinins' [patent_app_type] => B1 [patent_app_number] => 09/914893 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518273.pdf [firstpage_image] =>[orig_patent_app_number] => 09914893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560232 [patent_doc_number] => 06436932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Aminoalkyl substituted pyrrolo3,2-e pyridine and pyrrolo2,3-bpyrimidine derivatives: modulators of CRF1 receptors' [patent_app_type] => B1 [patent_app_number] => 09/947045 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9254 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436932.pdf [firstpage_image] =>[orig_patent_app_number] => 09947045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361654 [patent_doc_number] => 20020058666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => '2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands' [patent_app_type] => new [patent_app_number] => 09/942219 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8405 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058666.pdf [firstpage_image] =>[orig_patent_app_number] => 09942219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059765 [patent_doc_number] => 06852855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Synthesis of piperazine ring' [patent_app_type] => utility [patent_app_number] => 09/939406 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1237 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852855.pdf [firstpage_image] =>[orig_patent_app_number] => 09939406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1497689 [patent_doc_number] => RE037886 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2002-10-15 [patent_title] => '1-(1,2-Disubstituted piperidinyl)-4-substituted piperazine derivatives' [patent_app_type] => E1 [patent_app_number] => 09/935698 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18821 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037886.pdf [firstpage_image] =>[orig_patent_app_number] => 09935698 [rel_patent_id] =>[rel_patent_doc_number] =>)